Elsevier Business Intelligence Publications and Databases.
BIO Business Solutions® has partnered with Elsevier Business Intelligence, a leading provider of industry publications and databases, to provide discounts of Elsevier Business Intelligence's suite of products. Elsevier Business Intelligence places biopharma and medical device professionals, and those who focus on these industries at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis.
IN VIVO: The Business & Medicine Report, Start-Up: Emerging Medical Ventures, The RPM Report: Regulation/Policy/Market Access and Medtech Insight all provide superior analysis and commentary on healthcare business strategy, industry deal-making and marketplace trends.
“The Pink Sheet”, “The Gray Sheet”, PharmAsia News, Pharmaceutical Approvals Monthly, among others, provide the latest regulatory, legislative, and business news affecting the U.S. drug, biotechnology, medical device, and non-prescription drug industries.
The Strategic Transactions database is the most comprehensive deals database in the life science industry.
- Special member pricing available on new subscriptions to select EBI publications
- Special member pricing available for new purchases of the Strategic Transactions database
- Further discounting available for new combined purchases of a publication and database product
*Discounts are for new subscriptions only.
In addition to members of BIO, members of the following state and regional biotech associations can take advantage of this program:
For more information about the BIO-Elsevier program, contact Ida Stepinac of Elsevier Business Intelligence at 203-840-6260, or I.Stepinac@Elsevier.com.
To learn more about Elsevier Business Intelligence, visit www.ElsevierBI.com.